Meeting
2017 ASCO Annual Meeting
NGS to reveal heterogeneity between cerebrospinal fluid and plasma ctDNA among non-small cell lung cancer patients with leptomeningeal carcinomatosis.
Authors
Ben-Yuan Jiang
Division of Pulmonary Oncology, Cancer Center, Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
Ben-Yuan Jiang , Yangsi Li , Shaokun Chuai , Zhou Zhang , Jin-Ji Yang , Wenzhao Zhong , Qing Zhou , Yi-Long Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 9022)
DOI
10.1200/JCO.2017.35.15_suppl.9022
Abstract #
9022
Poster Bd #
348
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Genomic landscape differences in patients with advanced non-small cell lung cancer by sex and age.
First Author: ErinMarie Kimbrough
Poster
2021 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) in patients with advanced adrenocortical carcinoma.
First Author: Bassel Nazha
Poster
2020 ASCO Virtual Scientific Program
RELAY study of erlotinib (ERL) + ramucirumab (RAM) or placebo (PL) in EGFR-mutated metastatic non-small cell lung cancer (NSCLC): Biomarker analysis using circulating tumor DNA (ctDNA) in Japanese patients (pts).
First Author: Kazuto Nishio
Poster
2019 ASCO Annual Meeting
Circulating tumor DNA analysis (ctDNA) for genomic testing in NSCLC patients with isolated CNS progression.
First Author: Mihaela Aldea